Posted by on September 5, 2019 2:00 am
Tags: , , ,
Categories: News µ Newsjones

Drugs derived from Ivermectin, which makes human blood deadly to mosquitoes, could be available within two years

Human trials of new antimalarial drugs are in the pipeline after Kenyan scientists successfully used bacteria to kill the parasite that causes the disease.

The Kenya Medical Research Institute (Kemri) and global health partners say the breakthrough could potentially lead to the development of a new class of drugs in less than two years.

Continue reading…